(Q53550371)
Statements
FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study (English)
Claudio Verusio
Sandro Barni
Luca Rubino
Silvia Bozzarelli
Eugenio Villa
Carlo Carnaghi
Maria Chiara Tronconi
Chiara Gerardi
Francesca Galli
Irene Floriani
Annarita Destro
Carlotta Raschioni